Healthcare Medicare premium increase from Alzheimer’s drug to be lowered next year Healthcare / 2 months ago by Joseph Choi 05/27/22 4:30 PM ET
Policy Biogen CEO stepping down after Medicare decision on Alzheimer’s drug Policy / 3 months ago by Joseph Choi 05/03/22 10:03 AM ET
Healthcare Medicare finalizes decision to limit coverage of controversial Alzheimer’s drug to those in clinical trial Healthcare / 4 months ago by Peter Sullivan 04/07/22 5:10 PM ET
Healthcare Biogen halves price of controversial Alzheimer’s drug Healthcare / 8 months ago by Nathaniel Weixel 12/20/21 10:48 AM ET
Healthcare Sanders urges Biden to delay Medicare premium hike linked to Alzheimer’s drug Healthcare / 8 months ago by Nathaniel Weixel 12/03/21 4:40 PM ET
Healthcare Medicare premiums to jump in part due to pricey Alzheimer’s drug Healthcare / 9 months ago by Peter Sullivan 11/12/21 6:23 PM ET
Healthcare House panels press Biogen for documents on controversial Alzheimer’s drug Healthcare / 1 year ago by Peter Sullivan 07/12/21 5:11 PM ET
Healthcare Biogen CEO says $56K a year for new Alzheimer’s drug is a ‘fair’ price Healthcare / 1 year ago by Joseph Choi 06/07/21 4:35 PM ET
